| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |